Identification of novel mutation patterns in the parC gene of ciprofloxacin-resistant isolates of Neisseria gonorrhoeae

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 8, 1998, Pages 2103-2105

  Trees, David L ^a,c   Sandul, Amy L ^a   Whittington, William L ^b   Knapp, Joan S ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL;

EID: 0031879524     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.8.2103     Document Type: Article

References (20)

1. Belland, R. J., S. G. Morrison, C. Ison, and W. M. Huang. 1994. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates. Mol. Microbiol. 14:371-380.
2. Centers for Disease Control and Prevention. 1993. Sexually transmitted diseases treatment guidelines. Morbid. Mortal. Weekly Rep. 42(14):4-5.
3. Corkill, J. E., A. Percival, and M. Lind. 1991. Reduced uptake of ciprofloxacin in a resistant strain of Neisseria gonorrhoeae and transformation of resistance to other strains. J. Antimicrob. Chemother. 28:601-604.
4. Deguchi, T., M. Yasuda, M. Asano, K. Tada, H. Iwata, H. Komeda, T. Ezaki, I. Saito, and Y. Kawada. 1995. DNA gyrase mutations in quinolone-resistant clinical isolates of Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 29:561-563.
5. Deguchi, T., M. Yasuda, M. Nakano, S. Ozeki, T. Ezaki, S.-I. Maeda, I. Saito, and Y. Kawada. 1996. Rapid detection of point mutations of the Neisseria gonorrhoeae gyrA gene associated with decreased susceptibilities to quinolones. J. Clin. Microbiol. 34:2255-2258.
6. Deguchi, T., M. Yasuda, M. Nakano, S. Ozeki, T. Ezaki, I. Saito, and Y. Kawada. 1996. Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles. Antimicrob. Agents Chemother. 40:1020-1023.
7. Deguchi, T., M. Yasuda, M. Nakano, E. Kanematsu, S. Ozeki, E. Kanematsu, Y. Kawada, T. Ezaki, and I. Saito. 1996. Uncommon occurrence of mutations in the gyrB gene associated with quinolone resistance in clinical isolates of Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 40:2437-2438.
8. Deguchi, T., M. Yasuda, M. Nakano, E. Kanematsu, S. Ozeki, Y. Nishino, T. Ezaki, S.-I. Maeda, I. Saito, and Y. Kawada. 1997. Rapid screening of point mutations of the Neisseria gonorrhoeae parC gene associated with resistance to quinolones. J. Clin. Microbiol. 35:948-950.
9. Ferrero, L., B. Cameron, B. Manse, D. Lagneaux, J. Crouzet, A. Famechon, and F. Blanche. 1994. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target for fluoroquinolones. Mol. Microbiol. 13:641-653.
10. Knapp, J. S., J. A. Hale, K. Wintersheid, S. W. Neal, and W. L. Whittington. 1995. Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin. Antimicrob. Agents Chemother. 39:2442-2445.
11. Knapp, J. S., K. K. Fox, D. L. Trees, and W. L. Whittington. 1997. Fluoroquinolone resistance in Neisseria gonorrhoeae. Emerg. Infect. Dis. 3:33-39.
12. Knapp, J. S., M. R. Tam, R. C. Nowinski, K. K. Holmes, and E. G. Sandström. 1984. Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. J. Infect. Dis. 150:44-48.
13. Meyers, J. A., D. Sanchez, S. Elwell, and S. Falkow. 1976. Simple agarose gel electrophoretic method for the identification and characterization of plasmid deoxyribonucleic acid. J. Bacteriol. 127:1529-1537.
14. National Committee for Clinical Laboratory Standards. 1993. Approved standard M7-A3. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards, Wayne, Pa.
15. Rice, R. J., and J. S. Knapp. 1994. Antimicrobial susceptibilities of Neisseria gonorrhoeae representing five distinct resistance phenotypes. Antimicrob. Agents Chemother. 38:155-158.
16. Rice, R. J., and J. S. Knapp. 1994. Susceptibility of Neisseria gonorrhoeae associated with pelvic inflammatory disease to cefoxitin, ceftriaxone, clindamycin, gentamicin, doxycycline, azithromycin, and other antimicrobial agents. Antimicrob. Agents Chemother. 38:1688-1691.
17. Short, H. B., V. B. Ploscowe, J. S. Weiss, and F. E. Young. 1977. Rapid method for auxotyping multiple strains of Neisseria gonorrhoeae. J. Clin. Microbiol. 6:244-248.
18. Stein, D. C., R. J. Danaher, and T. M. Cook. 1991. Characterization of a gyrB mutation responsible for low-level nalidixic acid resistance in Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 35:622-626.
19. Tanaka, M., H. Fukuda, K. Hirai, M. Hosaka, T. Matsumoto, and J. Kumazawa. 1994. Reduced uptake and accumulation of norfloxacin in resistant strains of Neisseria gonorrhoeae isolated in Japan. Genitourin. Med. 70:253-255.
20. Yoshida, H., M. Bogaki, M. Nakamura, and S. Nakamura. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34:1271-1272.